Log In Sign up
The largest database of trusted experimental protocols

Architect anti hbc

Manufactured by Abbott
Visit Supplier
Sourced in United States, Germany

The ARCHITECT® anti-HBc is a laboratory equipment product designed to detect the presence of antibodies to the hepatitis B core antigen (anti-HBc) in human serum or plasma samples. It is an automated, chemiluminescent microparticle immunoassay (CMIA) used for the qualitative determination of anti-HBc.

Automatically generated - may contain errors

Lab products found in correlation

Architect hbsag, by Abbott (2 mentions) Architect anti hbs, by Abbott (2 mentions) Architect i2000 analyzer, by Abbott (1 mentions) Axsym, by Abbott (1 mentions)

Close spelling variants of this product

ARCHITECT Anti-HBc II Architect Anti-HBc assay Anti-HBc

2 protocols using architect anti hbc

1

Hepatitis B Serological Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were tested for HBsAg, HBcAb (total antibodies IgM and IgG), and HBsAb based on chemiluminescent microparticle immunoassays (CMIAs). These tests were performed using CE-approved kits (ARCHITECT® HBsAg, ARCHITECT® anti-HBc, ARCHITECT® anti-HBs) and the Architect i2000 analyzer (Abbott, Lake Forest, IL, USA).
Alshayea A.I., Eid G.E., El-Hazmi M.M, & Alhetheel A.F. (2016). Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia. Saudi Medical Journal, 37(10), 1114-1119.
+ Open protocol
+ Expand
2

HBV Serological Marker Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Testing for antibodies to HBV surface antigen (anti-HBs) and antibodies to HBV core antigen (anti-HBc) was performed using CMIA (ARCHITECT anti-HBs and ARCHITECT anti-HBc, Abbott Diagnostic Division, Wiesbaden, Germany). Samples giving borderline test results were retested. HBV surface antigen (HBsAg) was tested using CMIA (ARCHITECT HBsAg Abbott Diagnostic Division, Wiesbaden, Germany) and confirmed by neutralization test (AxSYM, Abbott Diagnostic Division, Wiesbaden, Germany). Samples were deemed HBsAg+ when positive at the neutralization test. Study subjects without available information on all three HBV markers (one case and seven controls) were excluded from analyses on HBV markers.
Taborelli M., Polesel J., Montella M., Libra M., Tedeschi R., Battiston M., Spina M., Di Raimondo F., Pinto A., Crispo A., Grimaldi M., Franceschi S., Dal Maso L, & Serraino D. (2016). Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy. Infectious Agents and Cancer, 11, 27.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!